Company Overview

LENZ THERAPEUTICS, INC.

LENZ
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
19M
2025 FY
Net Income
-82M
2025 FY
Shares Outstanding
29M
2025 FY
EPS
-2.85USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1815776
Exchange
Nasdaq
Location
US